Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine.
Saved in:
| Title: | Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine. |
|---|---|
| Authors: | Li HH; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA. Electronic address: hualin.li@merck.com., Xu J; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA., He L; Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, PA 19486, USA., Denny LI; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA., Rustandi RR; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA., Dornadula G; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA., Fiorito B; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA., Zhang ZQ; Analytical Research and Development, Merck & Co., Inc., West Point, PA 19486, USA. |
| Source: | Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Sep 20; Vol. 234, pp. 115523. Date of Electronic Publication: 2023 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-264X |
|---|---|
| DOI: | 10.1016/j.jpba.2023.115523 |
